Patents by Inventor Enkhtsetseg Purev

Enkhtsetseg Purev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATMENT OF PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA WITH MOSUNETUZUMAB AND LENALIDOMIDE
    Publication number: 20240043553
    Abstract: The present invention relates to the treatment of subjects having previously untreated follicular lymphoma (FL). More specifically, the invention pertains to the treatment of subjects having previously untreated FL by administering a combination of mosunetuzumab and lenalidomide.
    Type: Application
    Filed: June 21, 2023
    Publication date: February 8, 2024
    Inventors: Andrea KNAPP, Chi-Chung LI, Enkhtsetseg PUREV, Michael C. WEI
  • METHODS FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WITH MOSUNETUZUMAB AND LENALIDOMIDE
    Publication number: 20230190932
    Abstract: The present invention relates to the treatment of subjects having relapsed and/or refractory (R/R) follicular lymphoma (FL). More specifically, the invention pertains to the treatment of subjects having R/R FL by administering a combination of mosunetuzumab and lenalidomide.
    Type: Application
    Filed: October 28, 2022
    Publication date: June 22, 2023
    Inventors: Catherine GRANIER, Andrea Knapp, Chi-Chung Li, Carol Elaine O'Hear, Enkhtsetseg Purev, Michael C. Wei